Category: Pharma & Biotech

Zynerba Pharmaceuticals Announces Positive Meeting with U.S. Food and Drug Administration and Plans to Conduct a Single Pivotal Study of ZYN002 in Fragile X Syndrome to Support an NDA Filing

SHARE THIS POST Company Expects to Initiate Pivotal Study Mid-Year 2018 and Deliver Top-line Data in 2019 Devon, PA, March 5, 2018 – Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric...

Read More

Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals

SHARE THIS POST Grand Opening of First CBIS Pharmacies Expected Soon IRVINE, CA, March 05, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based...

Read More

India Globalization Capital Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)

SHARE THIS POST BETHESDA, Md., March 01, 2018 (GLOBE NEWSWIRE) — India Globalization Capital, Inc. (NYSE American:IGC) today announces that it has signed a Joint Development and Services Agreement with the prestigious...

Read More